Pliant Therapeutics Inc.

1.59
0.04 (2.58%)
At close: Mar 24, 2025, 3:56 PM
1.60
0.08%
After-hours: Mar 24, 2025, 04:02 PM EDT

Pliant Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a 1.58M 9.69M 7.57M 41.82M 57.05M n/a n/a
Cost of Revenue n/a n/a 3.68M 3.2M n/a n/a 666K n/a
Gross Profit n/a 1.58M 6M 4.37M 41.82M 57.05M -666K n/a
Operating Income -228.37M -184.15M -127.2M -19.99M -41.65M -1.23M -30.91M -18.35M
Interest Income n/a 24.08M 4.67M 272K 478K 816K 688K 16K
Pretax Income -210.3M -161.34M -123.32M -19.71M -41.53M -631K -30.28M -18.33M
Net Income -210.3M -161.34M -121.5M -17.91M -39.74M 185K -30.28M -20.62M
Selling & General & Admin 59.05M 57.93M 39.95M 27.56M 17.27M 10.93M 6.5M 3.82M
Research & Development 169.31M 127.8M 96.94M 77.55M 66.19M 47.35M 24.41M 14.53M
Other Expenses n/a n/a n/a -77.55M -366K -216K -49K n/a
Operating Expenses 228.37M 185.72M 136.88M 27.56M 83.46M 58.28M 30.91M 18.35M
Interest Expense 21.09M 1.27M 791K 272K 366K 216K n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 185.72M 136.88M 27.56M 83.46M 58.28M 30.91M 18.35M
Income Tax n/a n/a -1.82M -1.81M -1.79M -816K 639K 2.29M
Shares Outstanding (Basic) 60.54M 58.72M 42.02M 35.85M 35.55M 35.55M 16.51M 803.5K
Shares Outstanding (Diluted) 60.54M 58.72M 42.02M 35.85M 35.55M 35.55M 16.51M 803.5K
EPS (Basic) -3.47 -2.75 -2.89 -0.5 -1.12 0.01 -1.83 -25.67
EPS (Diluted) -3.47 -2.75 -2.89 -0.5 -1.12 0.01 -1.83 -25.67
EBITDA -228.37M -158.23M -118.85M -95.73M -40.34M -118K -30.25M -18.06M
Depreciation & Amortization n/a 1.84M 3.68M 3.2M 1.31M 1.11M 666K 292K